Molecular Partners AG (0QXX.L) LSE
3.07
-0.055(-1.76%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 126.35M |
| Enterprise Value | 36.94M |
| P/E Ratio | -1.94 |
| PEG Ratio | -0.3 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.64 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.66 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.66 |
| Return On Equity | -0.66 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.15M |
| EBITDA | -53.29M |
| Net Income | -61.65M |
| Diluted EPS | -1.65 |
Balance Sheet
| Total Cash | 78.77M |
| Total Cash/Share | 2.49 |
| Total Debt | 3.34M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 9.42 |
| Book Value Per Share | 1.83 |
Price History
| 52-Week Change | -2.7 |
| 52-Week High | 6.17 |
| 52-Week Low | 3.04 |
| Moving Average 50 Days | 3.8 |
| Moving Average 200 Days | 4.93 |
Statistics
| Average Volume | 6,578 |
| Shares Outstanding | 37.51M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
